Filing Details
- Accession Number:
- 0000950170-24-026472
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-05 18:16:08
- Reporting Period:
- 2024-03-01
- Accepted Time:
- 2024-03-05 18:16:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1756262 | Transmedics Group Inc. | TMDX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190128 | R James Tobin | C/O Transmedics Group, Inc. 200 Minuteman Road Andover MA 01810 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-01 | 200 | $81.41 | 233,391 | No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
Common Stock | Disposition | 2024-03-01 | 4,234 | $82.84 | 229,157 | No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
Common Stock | Disposition | 2024-03-01 | 5,746 | $83.63 | 223,411 | No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
Common Stock | Disposition | 2024-03-01 | 2,900 | $84.74 | 220,511 | No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
Common Stock | Disposition | 2024-03-01 | 300 | $85.48 | 220,211 | No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
No | 4 | S | Indirect | By the James R. Tobin 2012 Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,193 | Direct |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.25 to $83.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $83.26 to $84.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.28 to $85.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $85.39 to $85.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.